Fibrositis (fibromyalgia syndromes, myofascial pain syndromes) are a group of disorders characterized by chronic widespread aches and pains in the muscles, muscle sheath and connective tissues of tendons, muscles, bones and joints, with associated tenderness.
The pain and stiffness (fibromyalgia) may affect the whole body or may be restricted to certain parts of the body, as in myofascial pain syndromes. Fibromyalgia throughout the body is more common in women than in men. Men are more likely to develop myofascial pain or fibromyalgia in a particular area e.g. a shoulder ,from a work related or sports muscle strain injury.
It is a common condition seen in 4 to 11% of the population and is more prevalent in women. It can affect any age group. It is not serious or life-threatening, but persistent symptoms can be very disruptive.
Causes
Unknown. However, fibromyalgia may be triggered by mental or physical stress, inadequate sleep, an injury, exposure to dampness or cold, certain infections and possibly related to imbalance in brain chemicals or auto-immune disorder.
It is not a psychological disorder.
Prevention :
Avoid risk factors when possible.
Get adequate sleep.
General conditioning exercises
Scorpion venom could replace morphine as painkiller I
Scorpion venom is notoriously poisonous but it can potentially replace dangerous and addictive painkillers like morphine, says a new study.
Michael Gurevitz, professor, Tel Aviv University’s (TAU) Department of Plant Sciences, is investigating new ways for developing a novel painkiller based on natural compounds found in scorpion venom.
These compounds have gone through millions of years of evolution and some show high efficacy and specificity for certain components of the body with no side-effects, he says.
Peptide toxins found in scorpion venom interact with sodium channels in nervous and muscular systems - and some of these sodium channels communicate pain, says Gurevitz.
“The mammalian body has nine different sodium channels of which only a certain subtype delivers pain to our brain,” adds Gurevitz.
“We are trying to understand how toxins in the venom interact with sodium channels at the molecular level and particularly how some of the toxins differentiate among channel subtypes.”
“If we figure this out, we may be able to slightly modify such toxins, making them more potent and specific for certain pain mediating sodium channels,” Gurevitz continues.
“With this information, engineering of chemical derivatives that mimic the scorpion toxins would provide novel pain killers of high specificity that have no side effects.
In his research, Gurevitz is concentrating on the Israeli yellow scorpion, one of the most potent scorpions in the world. Its venom contains more than 300 peptides of which only a minor fraction has been explored.
The reason for working with this venom, he says, is the large arsenal of active components such as the toxins that have diversified during hundreds of millions of years under selective pressure.
During that process, some toxins have evolved with the capability to directly affect mammalian sodium channel subtypes whereas others recognise and affect sodium channels of invertebrates such as insects, says a university release.
This deviation in specificity is a lesson on how toxins may be manipulated at will by genetic engineering, he says.
Michael Gurevitz, professor, Tel Aviv University’s (TAU) Department of Plant Sciences, is investigating new ways for developing a novel painkiller based on natural compounds found in scorpion venom.
These compounds have gone through millions of years of evolution and some show high efficacy and specificity for certain components of the body with no side-effects, he says.
Peptide toxins found in scorpion venom interact with sodium channels in nervous and muscular systems - and some of these sodium channels communicate pain, says Gurevitz.
“The mammalian body has nine different sodium channels of which only a certain subtype delivers pain to our brain,” adds Gurevitz.
“We are trying to understand how toxins in the venom interact with sodium channels at the molecular level and particularly how some of the toxins differentiate among channel subtypes.”
“If we figure this out, we may be able to slightly modify such toxins, making them more potent and specific for certain pain mediating sodium channels,” Gurevitz continues.
“With this information, engineering of chemical derivatives that mimic the scorpion toxins would provide novel pain killers of high specificity that have no side effects.
In his research, Gurevitz is concentrating on the Israeli yellow scorpion, one of the most potent scorpions in the world. Its venom contains more than 300 peptides of which only a minor fraction has been explored.
The reason for working with this venom, he says, is the large arsenal of active components such as the toxins that have diversified during hundreds of millions of years under selective pressure.
During that process, some toxins have evolved with the capability to directly affect mammalian sodium channel subtypes whereas others recognise and affect sodium channels of invertebrates such as insects, says a university release.
This deviation in specificity is a lesson on how toxins may be manipulated at will by genetic engineering, he says.
